The company whose approval has been suspended may submit written or oral observations.
On receipt of these observations, the Director General of the Regional Health Agency has fifteen clear days in which to terminate the suspension or to convene the sub-committee in order to obtain an opinion prior to the temporary or definitive withdrawal of authorisation.
The sub-committee is then convened no later than one month after receipt of the interested party’s observations. If the committee is not convened, the suspension is lifted.